Publications by authors named "Hai-yan Cai"

The radioresistance of glioma is an important cause of treatment failure and tumor aggressiveness. In the present study, under performed with linear accelerator, the effects of 0.3 and 3.

View Article and Find Full Text PDF
Article Synopsis
  • Osimertinib, a third-generation EGFR inhibitor, shows promise in treating non-small cell lung cancer and induces cell death in CD34+ leukemia stem cells, particularly in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML).
  • The drug binds to specific cysteine residues on CD34 and inhibits certain signaling pathways, leading to selective apoptosis in these leukemia cells without harming normal CD34+ cells.
  • Clinical observations include positive responses in AML patients with high CD34 expression, suggesting osimertinib could be a new therapeutic option for myeloid leukemia due to its unique mechanism of action that doesn't rely on EGFR.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists found that when cells lack amino acids, a process happens that causes a protein called mTOR to get a special tag (ubiquitination), which stops it from doing its job.
  • This happens because without enough amino acids, a type of molecule called tRNAs build up, which signals another protein called GCN2 to interact with mTOR.
  • Their research shows a new way that cells can sense whether they have enough amino acids through a specific pathway involving GCN2 and another protein, FBXO22.
View Article and Find Full Text PDF

Fatty acid binding protein 4 (FABP4) plays a critical role in metabolism and inflammatory processes and therefore is a potential therapeutic target for immunometabolic diseases such as diabetes and atherosclerosis. Herein, we reported the identification of naphthalene-1-sulfonamide derivatives as novel, potent and selective FABP4 inhibitors by applying a structure-based design strategy. The binding affinities of compounds 16dk, 16do and 16du to FABP4, at the molecular level, are equivalent to or even better than that of BMS309403.

View Article and Find Full Text PDF

Deubiquitinating protease USP7 is a promising therapeutic target for cancer treatment, and interest in developing USP7 inhibitors has greatly increased. In the present study, we reported a series of natural pentacyclic triterpenes with USP7 inhibitory activity in vitro. Among them, both the ursane triterpenes and oleanane triterpenes were more active than the lupine triterpenes, whereas ursolic acid was the most potent with IC of 7.

View Article and Find Full Text PDF

Aim: Fatty acid-binding protein 4 (FABP4) plays an important role in maintaining glucose and lipid homeostasis. The aim of this study was to find new inhibitors of FABP4 for the treatment of type 2 diabetes.

Methods: Human FABP4 protein was expressed, and its inhibitors were detected in 1,8-ANS displacement assay.

View Article and Find Full Text PDF

Aim: To explore the function of the conserved aromatic cluster F213(5.47), F308(6.51), and F309(6.

View Article and Find Full Text PDF

Aim: To construct a reliable computational model for the classification of agonists and antagonists of 5-HT(1A) receptor.

Methods: Support vector machine (SVM), a well-known machine learning method, was employed to build a prediction model, and genetic algorithm (GA) was used to select the most relevant descriptors and to optimize two important parameters, C and r of the SVM model. The overall dataset used in this study comprised 284 ligands of the 5-HT(1A) receptor with diverse structures reported in the literatures.

View Article and Find Full Text PDF

Objective: To investigate the effects of lead exposure at different levels in utero on the teeth eruption and enamel development of rat offsprings.

Methods: 27 pregnant SD rats were divided into three groups randomly: high level lead group (HLG), low level lead group (LLG) and control group with nine rats in each group. The three groups from the gestation day to the end of the gestation were given either deionized water in control group or deionized water containing 200 mg/L Pb2+ as lead acetate through drinking method in high level lead experimental group and 50 mg/L Pb2+ as lead acetate through drinking method in low level lead experimental group.

View Article and Find Full Text PDF